Identification of Biomarkers for Precancerous Colorectal Lesions Utilizing Olink Proteomics and Colorectal Cancer Animal Models
Journal of Proteome Research · 06.11.2026 · 25 (11) · 5968-5984
DOI: 10.1021/acs.jproteome.6c00445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 25.10.2026. Verfasst von Xi Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chin…. Hauptthemen laut MEDLINE: Proteomics, Biomarkers, Tumor, Colorectal Neoplasms, Precancerous Conditions. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Committee?University Joint Innovation Fund, Committee–University Joint Innovation Fund.
Abstract (Originalsprache)
Neoplastic polyps are precancerous lesions of colorectal cancer (CRC), yet proteomic studies for stratifying their malignant potential remain limited. In this study, we used the Olink proteomics platform to systematically analyze the expression of inflammation- and oncology-related proteins in colorectal polyp tissues from 94 patients. The results showed that most inflammation- and oncology-related proteins were expressed at higher levels in neoplastic polyps than in non-neoplastic polyps. We further screened differentially expressed proteins using receiver operating characteristic (ROC) curve analysis, random forest, and LASSO regression. These findings were then validated using enzyme-linked immunosorbent assay (ELISA), public transcriptomic and single-cell transcriptomic datasets, and colonic immunohistochemistry (IHC) in colitis-associated colorectal cancer (CAC) and Apcmin/+ mouse models. In addition, 38 intestinal fluid samples were collected for supplementary validation. We ultimately identified ADAM8, WISP-1, MMP-1, and PPY as potential biomarkers of precancerous colorectal lesions. These proteins may provide valuable molecular evidence for deeper mechanistic studies of the CRC precancerous stage, early biomarker discovery, and prevention-oriented therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan610075, China.
- Oncology Teaching and Research Department, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan610075, China.
- Institute of Oncology, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan610075, China.
ORCID-Profile: Xueke Li
Förderung
- National Natural Science Foundation of China (NSFC)
- Committee?University Joint Innovation Fund
- Committee–University Joint Innovation Fund
Zitieren
APA
Fu, X., Jian, R., Xu, X., Tian, N., Feng, S., Jiang, Y., You, F., Zhou, X., & Li, X. (2026). Identification of Biomarkers for Precancerous Colorectal Lesions Utilizing Olink Proteomics and Colorectal Cancer Animal Models. Journal of Proteome Research, 25(11), 5968-5984. https://doi.org/10.1021/acs.jproteome.6c00445
Vancouver
Fu X, Jian R, Xu X, Tian N, Feng S, Jiang Y, et al. Identification of Biomarkers for Precancerous Colorectal Lesions Utilizing Olink Proteomics and Colorectal Cancer Animal Models. Journal of Proteome Research. 2026;25(11):5968-5984. doi:10.1021/acs.jproteome.6c00445
BibTeX
@article{Fu2026,
author = {Fu, Xi and Jian, Ruofan and Xu, Xingwei and Tian, Nihuan and Feng, Siqi and Jiang, Yifang and You, Fengming and Zhou, Xuelei and Li, Xueke},
title = {Identification of Biomarkers for Precancerous Colorectal Lesions Utilizing Olink Proteomics and Colorectal Cancer Animal Models},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {5968--5984},
doi = {10.1021/acs.jproteome.6c00445}
}
EUVIMED